N-n-Butyl Haloperidol Iodide, a Derivative of the Anti-psychotic Haloperidol, Antagonizes Hypoxia/Reoxygenation Injury by Inhibiting an Egr-1/ROS Positive Feedback Loop in H9c2 Cells.
N-n-Butyl Haloperidol Iodide, a Derivative of the Anti-psychotic Haloperidol, Antagonizes Hypoxia/Reoxygenation Injury by Inhibiting an Egr-1/ROS Positive Feedback Loop in H9c2 Cells.
复制标题
N-正丁基氟哌啶醇碘化物是抗精神病药物氟哌啶醇的衍生物,通过抑制 H9c2 细胞中的 Egr-1/ROS 正反馈环来拮抗缺氧/复氧损伤
DOI:
10.3389/fphar.2018.00019
复制
发表时间:
2018
影响因子:
5.6
通讯作者:
Shi G
中科院分区:
文献类型:
--
作者:
Sun T;Zhang Y;Zhong S;Gao F;Chen Y;Wang B;Cai W;Zhang Z;Li W;Lu S;Zheng F;Shi G
Early growth response-1 (Egr-1), a transcription factor which often underlies the molecular basis of myocardial ischemia/reperfusion (I/R) injury, and oxidative stress, is key to myocardial I/R injury. Silent information regulator of transcription 1(SIRT1) not only interacts with and is inhibited by Egr-1, but also downregulates reactive oxygen species (ROS) via the Forkhead box O1(FOXO1)/manganese superoxide dismutase (Mn-SOD) signaling pathway. N-n-butyl haloperidol iodide (F2), a new patented compound, protects the myocardium against myocardial I/R injury in various animal I/R models in vivo and various heart-derived cell hypoxia/reoxygenation (H/R) models in vitro. In addition, F2 can regulate the abnormal ROS/Egr-1 signaling pathway in cardiac microvascular endothelial cells (CMECs) and H9c2 cells after H/R. We studied whether there is an inverse Egr-1/ROS signaling pathway in H9c2 cells and whether the SIRT1/FOXO1/Mn-SOD signaling pathway mediates this. We verified a ROS/Egr-1 signaling loop in H9c2 cells during H/R and that F2 protects against myocardial H/R injury by affecting SIRT1-related signaling pathways. Knockdown of Egr-1, by siRNA interference, reduced ROS generation, and alleviated oxidative stress injury induced by H/R, as shown by upregulated mitochondrial membrane potential, increased glutathione peroxidase (GSH-px) and total SOD anti-oxidative enzyme activity, and downregulated MDA. Decreases in FOXO1 protein expression and Mn-SOD activity occurred after H/R, but could be blocked by Egr-1 siRNA. F2 treatment attenuated H/R-induced Egr-1 expression, ROS generation and other forms of oxidative stress injury such as MDA, and prevented H/R-induced decreases in FOXO1 and Mn-SOD activity. Nuclear co-localization between Egr-1 and SIRT1 was increased by H/R and decreased by either Egr-1 siRNA or F2. Therefore, our results suggest that Egr-1 inhibits the SIRT1/FOXO1/Mn-SOD antioxidant signaling pathway to increase ROS and perpetuate I/R injury. F2 inhibits induction of Egr-1 by H/R, thereby activating SIRT1/FOXO1/Mn-SOD antioxidant signaling and decreasing H/R-induced ROS, demonstrating an important mechanism by which F2 protects against myocardial H/R injury.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2008.11.110
发表时间:
2009-01-16
影响因子:
3.1
作者:
Chen, Chun-Juan;Yu, Wei;Wang, Wei
通讯作者:
Wang, Wei
DOI:
10.18632/aging.100470
发表时间:
2012-07
期刊:
Aging
影响因子:
--
作者:
Pardo PS;Boriek AM
通讯作者:
Boriek AM
DOI:
10.1146/annurev.pathol.4.110807.092250
发表时间:
2010
期刊:
Annual review of pathology
影响因子:
--
作者:
Haigis MC;Sinclair DA
通讯作者:
Sinclair DA
DOI:
10.1073/pnas.0400593101
发表时间:
2004-07-06
影响因子:
11.1
作者:
Daitoku, H;Hatta, M;Fukamizu, A
通讯作者:
Fukamizu, A
影响因子:
56.9
作者:
Brunet, A;Sweeney, LB;Greenberg, ME
通讯作者:
Greenberg, ME